DHR vs A — Key Metrics
| Metric | DHR (DANAHER CORP) | A (AGILENT TECHNOLOGIES INC) |
|---|---|---|
| Price | 228.58 | 177.33 |
| Market Cap | 160.81 Billion | 49.99 Billion |
| P/E (TTM) | 37.35 | 34.77 |
| P/B (Quarterly) | 3.068 | 5.741 |
| P/S (TTM) | 6.28 | 6.78 |
| Net Profit Margin (TTM) | 16.9 | 19.5 |
| Gross Margin (TTM) | 58.6 | 53.8 |
| ROE (TTM) | 8.2 | 20.5 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Underperform
Underperform
Recommendation Summary
Both stocks are projected to underperform the market over the next year. If you have to make a choice, Upfront Recommendation: DHR.
Financial Metrics
| DHR | Metrics | A |
|---|---|---|
| $228.58 | Price | $177.33 |
| — | Market Capitalization | — |
| 37.35 | Price to Earnings Ratio | 34.77 |
| 6.28 | Price to Sales | 6.78 |
| 27.96 | Price to FCF Ratio | 39.46 |
| 10.72 | Price to Gross Profit | 12.6 |
| 96.3 | Price to R&D | 103.08 |
| 10.88 | Price to Current Assets | 10.65 |
DHR vs A at a glance
Danaher Corp (DHR) and Agilent Technologies INC (A) are both Diagnostics & Research companies in the Healthcare sector. DHR is the larger, at $160.8 billion in market value against $50.0 billion for A, about 3.2 times the size.
On trailing-twelve-month figures, DHR trades at 37.4 times trailing earnings and A at 34.8; net profit margins are 16.9% and 19.5%.
The Upfront Investment model currently rates both Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.